Welcome to our dedicated page for Im Cannabis news (Ticker: IMCC), a resource for investors and traders seeking the latest updates and insights on Im Cannabis stock.
IM Cannabis Corp. reports developments tied to its medical cannabis platform serving patients in Israel and Germany. Company updates commonly address medical cannabis operations, regulatory and commercial positioning, operating and financial results, and the management of liquidity through note purchase agreements, convertible notes and common share purchase warrants.
Recurring IMCC news also includes Nasdaq listing-compliance notices, board and executive appointments, shareholder or governance matters, and disclosures related to material agreements and capital structure. The company’s announcements frame IM Cannabis as an international medical cannabis issuer with cross-border supply and compliance considerations in regulated cannabis markets.
IM Cannabis (NASDAQ: IMCC) signed a non-binding letter of intent to sell its European-focused subsidiary IMC Holdings to Slil.com Holding, controlled by CEO Oren Shuster. Slil would assume about C$10.5 million of IMC and IMC Holdings debt, subject to a definitive agreement and approvals.
IMC would retain its Israeli operations, aiming to improve working capital, cash flow and balance sheet strength while focusing on the local market and future investments.
IM Cannabis (Nasdaq: IMCC) filed a Form F-3 resale registration statement with the SEC on June 9, 2026. The filing covers 17,276,931 common shares tied to three 2026 convertible promissory notes and accompanying warrants. If declared effective, selling shareholders may resell these shares; IM Cannabis will not receive proceeds.
IM Cannabis (Nasdaq: IMCC) closed a US$225,000 convertible note financing with an institutional investor on June 3, 2026. The note carries a 10% original issue discount and 8% annual interest, rising to 14% on default, and is repayable only in common shares.
The conversion price is the lower of US$0.288 or 90% of the lowest 20-day VWAP, with a US$0.0576 floor and a 4.99% ownership cap. IM Cannabis also issued warrants for 781,250 shares at C$0.40, exercisable immediately until June 3, 2031. Net proceeds will fund general corporate purposes.
IM Cannabis (Nasdaq: IMCC) reported first quarter 2026 results for the period ended March 31, 2026. Revenue was $8.7 million, with gross profit of $1.4 million, an operating loss of $1.7 million, and a net loss of $2.5 million, or $0.38 per share.
The company reported a 22% year-over-year reduction in general and administrative expenses and highlighted ongoing cost optimization, working capital discipline, and liquidity management supported by convertible note financings during and after the quarter.
IM Cannabis (Nasdaq: IMCC) closed two convertible note financings bringing total gross proceeds to US$550,000 on May 7, 2026. The financings consist of a US$250,000 note (April 6, 2026) and a US$300,000 note (May 7, 2026), each issued at a 10% discount, with conversion into common shares and attached warrants.
Conversion prices, VWAP caps and 4.99% beneficial ownership limits apply; warrants are exercisable immediately and expire five years from issuance. Proceeds will be used for general corporate purposes and the company will file Form F-3 resale registration statements.
IM Cannabis (Nasdaq: IMCC) received a Nasdaq notice April 10, 2026, for non‑compliance with the $1.00 minimum bid price requirement under Nasdaq Rule 5550(a)(2).
The company has a 180‑day cure period to regain compliance, running through October 6, 2026, and shares will continue trading during the grace period.
IM Cannabis (Nasdaq: IMCC) reported audited 2025 results with revenue of C$54.7 million and a strong operational turnaround. Germany revenue surged >134% to C$36.3 million, representing over 66% of group revenue. Gross profit rose ~15% to C$9.7 million. Operating cash flow turned positive at C$4.7 million, and cash and restricted cash increased to C$3.3 million following financings including net proceeds of C$5.1 million.
The company also signed a non-binding LOI on March 17, 2026, to acquire 51% of Black Axe Technologies, marking a proposed strategic entry into defense and homeland security technology sectors.
IM Cannabis (NASDAQ: IMCC) signed a non-binding letter of intent dated March 17, 2026 to acquire 51% of Blackaxe Technologies, a Polish defense-tech firm focused on satellite intelligence, AI imagery analytics and counter-UAS/cyber interception solutions.
The proposed deal would diversify IMC beyond medical cannabis into defense and homeland security; completion is subject to due diligence, definitive agreements and regulatory approvals, and may not occur.
IM Cannabis (Nasdaq: IMCC) raised US$2,171,660.40 via two arm's‑length note financings announced Jan 26, 2026.
The First Note (issued Jan 7, 2026) has principal US$1,538,749 after a 10% issuance discount, 8% interest (rises to 14% on default), 18‑month maturity with lender extension option, conversion at the lower of US$1.47 or 90% of 20‑day low VWAP (floor US$0.29), and 228,150 five‑year warrants at C$3.45. The Second Note (issued Jan 20, 2026) has principal US$632,911.50 after 10% discount, identical interest and maturity terms, conversion at the lower of US$1.38 or 90% of 20‑day low VWAP (floor US$0.275), and 93,671 five‑year warrants at C$3.45.
Approximately US$500,000 of proceeds were used to repay existing creditors; the company agreed to file an F-3 registration within 30 trading days. All securities are subject to a four‑month and one‑day hold.
IM Cannabis (Nasdaq: IMCC) announced the appointment of Alon Dayan to its board of directors effective December 31, 2025. The company operates in Israel and Germany and named Dayan for his executive experience in homeland security technology and systems integration.
Dayan is CEO of KeepZone AI since 2025 and founder/CEO of L1-Systems since 2014, where he led projects in homeland security, intelligence systems and telecommunications across Latin America, Eastern Europe, and Western Europe. His prior roles include CEO of Virtual Crypto Technologies and business development at Elbit Systems. He holds a B.A. in Electrical and Electronic Engineering from Ariel University.